Maplight Therapeutics, Inc. · NASDAQ:MPLT
Gillis Jonathan sold 36,979 Maplight Therapeutics, Inc. shares (Form 4)
Traded Jul 15 to Jul 17, 2026 · Filed Jul 20, 2026
From Jul 15 to Jul 17, 2026, Gillis Jonathan (CAO and Interim CFO) sold 36,979 Maplight Therapeutics, Inc. shares at an average US$37.12 for US$1.37M under a trading plan, leaving 144,240 shares. Filed Jul 20, 2026 (Form 4).
- Sold
- 36,979 shares
- Price
- US$37.12 average (US$36.13 to US$38.17)
- Value
- US$1.37M
- Holding after
- 144,240 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CAO and Interim CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Voting Common Stock | Sale | 5,356 | US$36.13 | 175,863 | Direct |
| Jul 15, 2026 | Voting Common Stock | Sale | 4,699 | US$36.94 | 171,164 | Direct |
| Jul 16, 2026 | Voting Common Stock | Sale | 6,979 | US$36.66 | 164,185 | Direct |
| Jul 16, 2026 | Voting Common Stock | Sale | 1,476 | US$37.44 | 162,709 | Direct |
| Jul 17, 2026 | Voting Common Stock | Sale | 600 | US$36.51 | 162,109 | Direct |
| Jul 17, 2026 | Voting Common Stock | Sale | 16,969 | US$37.61 | 145,140 | Direct |
| Jul 17, 2026 | Voting Common Stock | Sale | 900 | US$38.17 | 144,240 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Gillis Jonathan
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Gillis Jonathan · Aug 19, 2026
- Form 4 · Gillis Jonathan · Apr 29, 2026
- Form 4 · Gillis Jonathan · Apr 17, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026